Myelodysplastic syndromes trials in Brazil

4 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

  Where

  Curitiba, Jaú, Joinville, Porto Alegre, Rio de Janeiro, Santo André, São José do Rio Preto, São Paulo

  Age

  18 years and over

  People

  225 worldwide

  Run by

  Takeda

  See details and how to joinNCT06499285 · EU 2024-516009-22-00
• Phase 3Taking people
  A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Lower Risk Myelodysplastic Syndromes (LR-MDS) Who Need Regular Blood Transfusions

  Where

  Jaú, Joinville, Porto Alegre, Salvador, Santos, São Paulo

  Age

  18 years and over

  People

  300 worldwide

  Run by

  Takeda

  See details and how to joinNCT07422480 · EU 2025-523544-12-00
• Phase 3Taking people
  Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation

  Where

  Curitiba, São Paulo

  Age

  18 years and over

  People

  48 worldwide

  Run by

  Institut de Recherches Internationales Servier

  See details and how to joinNCT06465953 · EU 2023-510155-37-00
• Phase 1/2Taking people
  PTCy and ATG for MSD and MUD Transplants

  Where

  Rio de Janeiro

  Age

  18 years to 60 years

  People

  50

  Run by

  Instituto Nacional de Cancer, Brazil

  See details and how to joinNCT06299462